Octavio Marquez - 11 Mar 2022 Form 3 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role: President and CEO
Signature: Jonathan B. Leiken, Attorney-in-fact for Octavio Marquez
Issuer symbol: DBD
Transactions as of: 11 Mar 2022
Net transactions value: $0
Form type: 3
Filing time: 16 Mar 2022, 16:38:38 UTC
Next filing: 12 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DBD	Common Shares						276,928	11 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DBD	Non-Qualified Stock Option							11 Mar 2022	Common Shares	15,885	$34.13	Direct	F2
holding	DBD	Non-Qualified Stock Option							11 Mar 2022	Common Shares	22,735	$32.33	Direct	F2
holding	DBD	Non-Qualified Stock Option							11 Mar 2022	Common Shares	16,388	$27.39	Direct	F2
holding	DBD	Non-Qualified Stock Option							11 Mar 2022	Common Shares	37,996	$26.60	Direct	F3
holding	DBD	Non-Qualified Stock Option							11 Mar 2022	Common Shares	19,786	$18.75	Direct	F3
holding	DBD	Non-Qualified Stock Option							11 Mar 2022	Common Shares	33,843	$4.08	Direct	F3
holding	DBD	Non-Qualified Stock Option							11 Mar 2022	Common Shares	9,327	$11.96	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Number includes restricted stock units.
F2	Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F3	Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.